Stem cell tourism prepares for take-off
Though prohibited in the West, innovative treatment in Eastern Europe and Asia is attracting a growing number of desperately ill people.
In 2004, during the first semester of his M.B.A. at Harvard Business School, Avichai Kremer felt that his right hand was steadily weakening. Eight months later he was diagnosed with the incurable atrophic disease ALS (Amyotrophic Lateral Sclerosis, or “Lou Gehrig’s disease”), which damages the connections between nerve cells and muscles and causes a slow loss of motor abilities...
Like us on Facebook and get articles directly in your news feed